[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)

NCT02562989 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Amnestic Mild Cognitive Impairment

Interventions

DRUG: [18F]MK-6240, ~185 MBq
DRUG: [18F]MK-6240, ~160 MBq

Sponsor

Merck Sharp & Dohme LLC